\BOOKMARK [0][-]{chapter*.1}{Resumen}{}% 1
\BOOKMARK [0][-]{chapter*.2}{Abstract}{}% 2
\BOOKMARK [0][-]{chapter*.3}{Índice general}{}% 3
\BOOKMARK [0][-]{chapter*.4}{Lista\040de\040abreviaturas}{}% 4
\BOOKMARK [0][-]{chapter*.5}{Índice de figuras}{}% 5
\BOOKMARK [0][-]{chapter*.6}{Índice de tablas}{}% 6
\BOOKMARK [0][-]{chapter.1}{Introducción}{}% 7
\BOOKMARK [1][-]{section.1.1}{El género Oncorhynchus}{chapter.1}% 8
\BOOKMARK [2][-]{subsection.1.1.1}{Situación actual en Chile}{section.1.1}% 9
\BOOKMARK [1][-]{section.1.2}{Sistema\040inmune\040en\040peces}{chapter.1}% 10
\BOOKMARK [1][-]{section.1.3}{Inmunidad\040en\040mucosas}{chapter.1}% 11
\BOOKMARK [2][-]{subsection.1.3.1}{Inmunidad\040Branquial}{section.1.3}% 12
\BOOKMARK [1][-]{section.1.4}{Inmunomoduladores}{chapter.1}% 13
\BOOKMARK [2][-]{subsection.1.4.1}{-glucanos}{section.1.4}% 14
\BOOKMARK [0][-]{chapter.2}{Hipótesis}{}% 15
\BOOKMARK [0][-]{chapter.3}{Objetivo\040General}{}% 16
\BOOKMARK [1][-]{section.3.1}{Objetivos Específicos}{chapter.3}% 17
\BOOKMARK [0][-]{chapter.4}{Materiales y Métodos}{}% 18
\BOOKMARK [1][-]{section.4.1}{Material Biológico y Bioensayo}{chapter.4}% 19
\BOOKMARK [2][-]{subsection.4.1.1}{Peces}{section.4.1}% 20
\BOOKMARK [2][-]{subsection.4.1.2}{Dieta}{section.4.1}% 21
\BOOKMARK [2][-]{subsection.4.1.3}{Parametros\040fisicoquimicos\040del\040ensayo}{section.4.1}% 22
\BOOKMARK [2][-]{subsection.4.1.4}{Anticuerpos}{section.4.1}% 23
\BOOKMARK [1][-]{section.4.2}{Desafío y Controles}{chapter.4}% 24
\BOOKMARK [1][-]{section.4.3}{Muestreo}{chapter.4}% 25
\BOOKMARK [1][-]{section.4.4}{Extracción de RNA}{chapter.4}% 26
\BOOKMARK [2][-]{subsection.4.4.1}{Cuantificación e Integridad de RNA}{section.4.4}% 27
\BOOKMARK [2][-]{subsection.4.4.2}{Sintesis\040de\040cDNA}{section.4.4}% 28
\BOOKMARK [1][-]{section.4.5}{PCR\040en\040Tiempo\040Real\040\(qPCR\)}{chapter.4}% 29
\BOOKMARK [2][-]{subsection.4.5.1}{Partidores}{section.4.5}% 30
\BOOKMARK [2][-]{subsection.4.5.2}{Estandarización de partidores}{section.4.5}% 31
\BOOKMARK [1][-]{section.4.6}{Extracción de Proteínas}{chapter.4}% 32
\BOOKMARK [2][-]{subsection.4.6.1}{Cuantificación de Proteínas}{section.4.6}% 33
\BOOKMARK [1][-]{section.4.7}{ELISA\040Indirecto}{chapter.4}% 34
\BOOKMARK [2][-]{subsection.4.7.1}{Activación de la placa}{section.4.7}% 35
\BOOKMARK [2][-]{subsection.4.7.2}{Bloqueo de sitios inespecíficos}{section.4.7}% 36
\BOOKMARK [2][-]{subsection.4.7.3}{Incubación primer anticuerpo}{section.4.7}% 37
\BOOKMARK [2][-]{subsection.4.7.4}{Incubación segundo anticuerpo y revelado}{section.4.7}% 38
\BOOKMARK [1][-]{section.4.8}{Cortes histológicos}{chapter.4}% 39
\BOOKMARK [2][-]{subsection.4.8.1}{Tinción Hematoxilina-eosina}{section.4.8}% 40
\BOOKMARK [1][-]{section.4.9}{Inmunofluorescencia}{chapter.4}% 41
\BOOKMARK [2][-]{subsection.4.9.1}{Desparafinización e Hidratación}{section.4.9}% 42
\BOOKMARK [2][-]{subsection.4.9.2}{Bloqueo}{section.4.9}% 43
\BOOKMARK [2][-]{subsection.4.9.3}{Incubación de anticuerpo primario}{section.4.9}% 44
\BOOKMARK [2][-]{subsection.4.9.4}{Incubación anticuerpo secundario y tinción de DNA \(Núcleos\)}{section.4.9}% 45
\BOOKMARK [2][-]{subsection.4.9.5}{Montaje}{section.4.9}% 46
\BOOKMARK [1][-]{section.4.10}{Microscopía Confocal}{chapter.4}% 47
\BOOKMARK [1][-]{section.4.11}{Analisis Estadístico}{chapter.4}% 48
\BOOKMARK [2][-]{subsection.4.11.1}{Coeficiente de correlación de Pearson \(R\)}{section.4.11}% 49
\BOOKMARK [0][-]{chapter.5}{Resultados}{}% 50
\BOOKMARK [1][-]{section.5.1}{Bioensayo}{chapter.5}% 51
\BOOKMARK [1][-]{section.5.2}{Extracción y Cuantificación de RNA}{chapter.5}% 52
\BOOKMARK [1][-]{section.5.3}{Estandarización de Partidores}{chapter.5}% 53
\BOOKMARK [2][-]{subsection.5.3.1}{EF-1}{section.5.3}% 54
\BOOKMARK [2][-]{subsection.5.3.2}{IL-12}{section.5.3}% 55
\BOOKMARK [2][-]{subsection.5.3.3}{TNF-}{section.5.3}% 56
\BOOKMARK [2][-]{subsection.5.3.4}{IFN-}{section.5.3}% 57
\BOOKMARK [2][-]{subsection.5.3.5}{IL-1}{section.5.3}% 58
\BOOKMARK [2][-]{subsection.5.3.6}{iNOS}{section.5.3}% 59
\BOOKMARK [1][-]{section.5.4}{PCR\040en\040tiempo\040real}{chapter.5}% 60
\BOOKMARK [2][-]{subsection.5.4.1}{TNF-}{section.5.4}% 61
\BOOKMARK [2][-]{subsection.5.4.2}{IFN-}{section.5.4}% 62
\BOOKMARK [2][-]{subsection.5.4.3}{IL-1}{section.5.4}% 63
\BOOKMARK [2][-]{subsection.5.4.4}{iNOS}{section.5.4}% 64
\BOOKMARK [2][-]{subsection.5.4.5}{IL-12}{section.5.4}% 65
\BOOKMARK [1][-]{section.5.5}{Extracción y Cuantificación de Proteínas}{chapter.5}% 66
\BOOKMARK [1][-]{section.5.6}{Validación de anticuerpos}{chapter.5}% 67
\BOOKMARK [2][-]{subsection.5.6.1}{Anticuerpos\040producidos\040en\040conejo}{section.5.6}% 68
\BOOKMARK [2][-]{subsection.5.6.2}{Anticuerpos producidos en ratón}{section.5.6}% 69
\BOOKMARK [1][-]{section.5.7}{ELISAs\040Indirectos}{chapter.5}% 70
\BOOKMARK [2][-]{subsection.5.7.1}{TNF-}{section.5.7}% 71
\BOOKMARK [2][-]{subsection.5.7.2}{IFN-}{section.5.7}% 72
\BOOKMARK [2][-]{subsection.5.7.3}{IL-1}{section.5.7}% 73
\BOOKMARK [2][-]{subsection.5.7.4}{iNOS}{section.5.7}% 74
\BOOKMARK [2][-]{subsection.5.7.5}{IL-12}{section.5.7}% 75
\BOOKMARK [1][-]{section.5.8}{Tinción Hematoxilina-eosina}{chapter.5}% 76
\BOOKMARK [1][-]{section.5.9}{Inmunofluorescencia}{chapter.5}% 77
\BOOKMARK [2][-]{subsection.5.9.1}{TNF-}{section.5.9}% 78
\BOOKMARK [2][-]{subsection.5.9.2}{IFNg-}{section.5.9}% 79
\BOOKMARK [2][-]{subsection.5.9.3}{IL-1}{section.5.9}% 80
\BOOKMARK [2][-]{subsection.5.9.4}{iNOS}{section.5.9}% 81
\BOOKMARK [1][-]{section.5.10}{Correlación}{chapter.5}% 82
\BOOKMARK [0][-]{chapter.6}{Discusiones}{}% 83
\BOOKMARK [1][-]{section.6.1}{Objetivo\0401}{chapter.6}% 84
\BOOKMARK [1][-]{section.6.2}{Objetivo\0402}{chapter.6}% 85
\BOOKMARK [1][-]{section.6.3}{Objetivo\0403}{chapter.6}% 86
\BOOKMARK [0][-]{chapter.7}{Conclusiones}{}% 87
\BOOKMARK [0][-]{chapter.8}{Bibliografía}{}% 88
